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Artemisia afra is one of the most widely used medicinal plants in African traditional medicine and is commonly administered in polyherbal
combinations to treat respiratory infections. Focussing on plant volatiles, the aim of this study was to provide scientific evidence for the
antimicrobial activity of A. afra (principle plant) in combination with essential oils from three medicinal aromatic plants; Agathosma betulina,
Eucalyptus globulus and Osmitopsis asteriscoides. In vitro minimum inhibitory concentration (MIC) assays were undertaken on four pathogens
(Enterococcus faecalis ATCC 29212, Moraxella catarrhalis ATCC 23246, Klebsiella pneumoniae NCTC 9633 and Cryptococcus neoformans
ATCC 90112) to determine antimicrobial efficacy of the oils and their combinations. The fractional inhibitory concentration (FIC) and
isobolograms were used to interpret pharmacodynamic interactions such as synergy, antagonism or additive profiles. The antimicrobial activity of
the individual oils mostly displayed moderate activity. Predominantly, additive interactions were noted. The most prominent synergistic
interaction (FIC value of 0.5) was observed when A. afra was combined with O. asteriscoides in the 8:2 ratio (eight parts A. afra with two parts
O. asteriscoides) against C. neoformans. No antagonistic interactions were evident.
© 2010 SAAB. Published by Elsevier B.V.All rights reserved.Keywords: Agathosma betulina; Artemisia afra; Antimicrobial; Eucalyptus globulus; Essential oil; Osmitopsis asteriscoides; Synergistic and additive interactions1. Introduction
Artemisia afra Jacq. ex Willd., commonly referred to as
African wormwood, is one of the most widely used traditional
medicines in southern Africa (Watt and Breyer-Brandwijk,
1962; Graven et al., 1992; Thring and Weitz, 2006; Van Wyk et
al., 2009). This highly aromatic indigenous medicinal plant is
abundantly distributed throughout the mountainous regions of
the South Western Cape and extends northwards, through the
Limpopo Province (South Africa) and into tropical east Africa
(Van Wyk et al., 2009). Due to its natural abundance and wide
spectrum of medicinal use (Watt and Breyer-Brandwijk, 1962;
Von Koenen, 1996; Van Wyk and Wink, 2004; Thring and
Weitz, 2006; Van Wyk et al., 2009), it has been the preferred
treatment by traditional healers. A. afra is well known for the⁎ Corresponding author.
E-mail address: Sandy.vanvuuren@wits.ac.za (S.F. Van Vuuren).
0254-6299/$ - see front matter © 2010 SAAB. Published by Elsevier B.V.All righ
doi:10.1016/j.sajb.2010.07.003treatment of upper and lower respiratory tract infections, where
symptoms include chills, coughs, throat infections, colds, fever,
inflammation of the throat, bronchitis and blocked nose.
Treatment is administered, either by inserting fresh leaves into
the nostril or by the administration of infusions, decoctions, in
steam inhalation and/or used as a gargle (Watt and Breyer-
Brandwijk, 1962; Hutchings et al., 1996; Van Wyk and Wink,
2004; Van Wyk et al., 2009).
A. afra also exhibits potent pharmacological activities
including antimicrobial, antioxidant, CNS-effects (sedative,
antidepressant), cardiovascular, and spasmolytic activity which
has been well documented and reviewed recently by Liu et al.
(2009). In relation to the anti-infective properties, A. afra has
shown inhibitory activity against some Gram-positive and
Gram-negative bacteria, fungi, as well as protozoa (Graven et
al., 1992; Bruneton, 1995; Poswal and Witbooi, 1997; Mangena
and Muyima, 1999; Huffman et al., 2002; Muyima et al., 2002;
Van Vuuren and Viljoen, 2006; Viljoen et al., 2006a; Vants reserved.
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activity of A. afra (MIC value of 1.57 mg/ml against
Mycobacterium smegmatis) demonstrated potential activity
against respiratory pathogens (Mativandlela et al., 2008).
Even though the antimicrobial activity of A. afra has been
thoroughly studied using disc diffusion, dilution and time-kill
assays, validation on the combined use with other plant species
is lacking. This is surprising, as the use of A. afra in
combination with other medicinal plants has been widely
documented in the ethnobotanical literature (Table 1). Based on
the ethnobotanical data summarised in Table 1, the oils from
selected aromatic plants (Agathosma betulina, Eucalyptus
globulus, and Osmitopsis asteriscoides) were investigated to
determine if synergistic antimicrobial interactions were appar-
ent when combined with A. afra.
A. betulina (P.J. Bergius) Pillans, belonging to the Rutaceae
family, is more commonly known as “buchu”. It is an aromatic,
round leafed perennial shrub, with a long-standing reputation of
commercial importance (Van Wyk, 2008). The essential oil is
known to have therapeutic properties particularly for treating
respiratory conditions such as the treatment of fever, coughs,
colds, and flu (Simpson, 1998; Moolla, 2006; Viljoen et al.,
2006b; Moolla and Viljoen, 2008).
E. globulus Labill. is commonly known as blue gum and
belongs to the family Myrtaceae. It is a very large tree (up to
60 m in height) with a characteristic shedding bark (Horn et al.,
1964; Van Wyk and Wink, 2004). The essential oil is colourless
or pale yellow, and it has an aromatic camphoraceous odour
(Watt and Breyer-Brandwijk, 1962). Although used extensively
as an indigenous medicinal plant in Australia and Tasmania
(Jordan et al., 1993; Dutkowski and Potts, 1999; Van Wyk andTable 1
Traditional use of A. afra in combination with other plant species for the treatment
Plants in combination Uses
A. afra and E. globulus Respiratory complaints
A. afra and A. betulina Respiratory complaints
A. afra and Zanthoxylum capense The Europeans and Africans
use it in febrile conditions, and
it is used as a treatment for colds
A. afra and O. asteriscoides Respiratory complaints
A. afra, E. globulus and
Leonotis microphylla
Fever, chest infections and
digestive disturbances
A. afra, Z. capense and
Allium sativum
Respiratory complaints
A. afra and Lippia javanica Fevers, respiratory complaints,
measles and as a prophylactic
against lung inflammations
A. afra, O. asteriscoides and
E. globulus
Respiratory complaints
A. afra and Tetradenia riparia and salt Coughs
A. afra and Alepidea amatymbica Colds and flu
A. afra and Warburgia salutaris Acute bronchitis, coughs from
colds or flu, fever
A. afra, A. amatymbica and
Leonotis leonurus
Asthma
A. afra, W. salutaris and
Acorus calamus
Chronic bronchitis
and emphysemaWink, 2004), E. globulus is also used in South Africa, as a
household remedy for colds as well as an ingredient in herbal
nasal preparations (Watt and Breyer-Brandwijk, 1962; Felha-
ber, 1997). E. globulus essential oil has been widely studied and
said to have a broad spectrum of antibacterial and antifungal
activity (Tewari and Akhila, 1985; Zakarya et al., 1993;
Cimanga et al., 2002; Sartorelli et al., 2007; Ghalem and
Mohamed, 2008a,b).
O. asteriscoides (P.J. Bergius) Less. from the Asteraceae
family, is commonly referred to as bels (Van Wyk et al., 2009).
It is a vigorous, branched glabrous shrub, which has a strong
camphor odour (Bremer, 1972; Van Wyk et al., 2009). The
leaves are oblong and glandular, having numerous diminutive
oil-containing glands on the surface (Van Wyk et al., 2009).
This Cape-Dutch remedy has been traditionally used to treat
various ailments ranging from inflammation, cuts, swellings
chest complaints, intestinal disorders, fevers to respiratory
related illnesses (Watt and Breyer-Brandwijk, 1962; Scott et al.,
2004; Van Wyk et al., 2009).
2. Material and methods
2.1. Plant collection and distillation of essential oils
Leaves and stems of A. afra were collected from the
Klipriviersburg Nature Reserve in Klipriviersburg, South of
Johannesburg. O. asteriscoides leaves were collected from
Hermanus, Cape Town. A. betulina leaves were purchased from
Warren Chem Specialties (South Africa). E. globulus leaves were
collected fromCresta, NorthWestern Johannesburg,Gauteng.All
plant collections were carried out in the summer months of 2007.of respiratory complaints.
Administration References
Crushed leaves or steam from
infusions are inhaled or decoctions
are taken
Watt and Breyer-Brandwijk, 1962;
Hutchings et al. (1996)
Herbal wine Watt and Breyer-Brandwijk, (1962)
A decoction and an infusion of
the leaf is used
Watt and Breyer-Brandwijk (1962)
Tincture Watt and Breyer-Brandwijk (1962)
Infusion Watt and Breyer-Brandwijk (1962)
Decoction Watt and Breyer-Brandwijk (1962)
Infusion, taken with milk Watt and Breyer-Brandwijk (1962)
Infusion, tincture Watt and Breyer-Brandwijk (1962);
Van Wyk et al. (2009)
Decoctions Hutchings et al. (1996)
Leaves and root/rhizome Jäger (2003)
Leaves and bark Felhaber (1997); Jäger (2003)
Leaves, root and leaves Felhaber (1997)
Leaves, bark and rhizome Felhaber (1997)
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SFVV61, O. asteriscoides— SFVV23, A. betulina— SFVV13,
andE. globulus— SFVV33) were deposited in theDepartment of
Pharmacy and Pharmacology, University of the Witwatersrand.
Plant identification was confirmed by A. Viljoen. As many of the
traditional uses and preparation of the remedies allude to the
volatile constituents (e.g. inhalation therapy and preparation of
tinctures) the essential oils from each plant were distilled by
conventional hydro-distillation in a Clevenger-type apparatus.
Leaves and stems were heated, the essential oils condensed in a
cooling system and thereafter decanted after 3 h.
2.2. Antimicrobial susceptibility tests
All microbiological techniques, culture and media preparation
were undertaken as described in the CLSI/NCCLS (2003)
guidelines. Reference microbial strains (Enterococcus faecalis
ATCC 29212, Moraxella catarrhalis ATCC 23246, Klebsiella
pneumoniae NCTC 9633 and Cryptococcus neoformans ATCC
90112)were selected on the basis of their respiratory pathogenesis
(Bannister et al., 2000;Verduin et al., 2002). Strainswere obtained
from the National Health Laboratory Services (NHLS) and sub-
cultured from stock agar plates, where purity was confirmed. The
bacteriawere cultured in Tryptone Soya broth (TSB) for 24 h. The
yeast (C. neoformans), was incubated for 48 h. Cultures were
prepared for micro-dilution assays using a 1:100 dilution, yielding
an approximate inoculum size of 1×106 colony forming units
(CFU)/ml). The minimum inhibitory concentration (MIC) micro-
dilution assay was carried out, as described by Van Vuuren and
Viljoen (2009). Starting concentrations of all essential oils at
128 mg/ml in acetonewere prepared. Conventional antimicrobials
i.e. ciprofloxacin for the bacteria and amphotericin B for the yeast
(C. neoformans) were included in all repetitions to confirm the
antimicrobial susceptibility.
2.3. Fractional inhibitory concentration (FIC)
As described by Van Vuuren (2007), the minimum
inhibitory concentration (MIC) data was used to calculate the
fractional inhibitory concentration (FIC) using the following
equation:
FICI =
MIC að Þ in combination with bð Þ
MIC að Þ independently
FICII =
MIC að Þ in combination with bð Þ
MIC bð Þ independently :
(a) represents A. afra and (b) represents either A. betulina,
E. globulus or O. asteriscoides. The sum of the FIC, known as
the FIC index was calculated as:
FICindex = FICI + FICII :
The FIC index was adapted from Odds (2003) and modified
to include an additive interpretation (Schelz et al., 2006; Iten etal., 2009). This was used to determine the correlation between
the two plant essential oils and may be classified as either
synergistic (≤0.5), additive (N0.5–1.0), non-interactive
(N1.0–≤4.0) or antagonistic (N4.0).
2.4. Isobologram construction
While the FIC data gives an indication of the interaction
between two plant combinations, a more in-depth approach
(graphical isobolograms) is presented, which considers the
different ratios at which the two plant samples were combined
(Van Vuuren, 2007). Combinations of A. afra with either
A. betulina, E. globulus or O. asteriscoides were prepared in
nine ratios i.e. 9:1; 8:2; 7:3; 6:4; 5:5; 4:6; 3:7; 2:8 and 1:9. MIC
values were determined for all nine ratios as well as for the
essential oils independently for all plant combinations.
Isobolograms were constructed using Graphpad Prism® to
present the mean MIC values of the combinations as ratios,
according to the equation;
X =
MIC value of combination of essential oils
MIC value of essential oil independently
Y =
MIC value of combination of essential oils
MIC value of essential oil independently
The isobolograms were interpreted by examining the data
points for each ratio in relation to the MICs for the oils
independently. The interpretation of the FIC index was used to
analyse interactions and thus ratio points falling below and/or
on the 0.5 line of the isobologram were interpreted as
synergistic. Points between 0.5 and/on the 1.0 line were
interpreted as additive and points above the 1.0 line were
defined as either non-interactive (N1.0 and 4.0) or antagonistic
(N4.0). Positive controls (ciprofloxacin for the bacteria and
amphotericin B for C. neoformans) were included in all
repetitions to confirm the antimicrobial susceptibility. Negative
controls were included to confirm sterility and effect of
solvents. All tests were undertaken at least in duplicate.
Separate experimental procedures were undertaken on selected
combinations to ensure uniformity of results.
3. Results and discussion
3.1. Antimicrobial susceptibility tests
The antimicrobial activity of the individual oils mostly
displayed moderate activity (Table 2). The MIC values for
A. afra ranged between 2.6 and 9.3 mg/ml, depending on the
pathogen studied. The MIC values of E. globulus and
O. asteriscoides essential oils ranged from 1.3 to 8.0 mg/ml and
0.6 to 8.0 mg/ml respectively. A. betulina displayed poor
antimicrobial activity (MIC 6.0–16.0 mg/ml) activity.
C. neoformans was the most sensitive pathogen against all tested
oils.
Table 2
MIC (mg/ml) values of A. afra, A. betulina, O. asteriscoides and E. globulus against four pathogens.
Essential oil plant sample Test micro-organism
M. catarrhalis
ATCC 23246
K. pneumoniae
NCTC 9633
E. faecalis
ATCC 29212
C. neoformans
ATCC 90112
A. afra 8.0 9.3 8.7 2.6
A. betulina 8.0 16.0 8.0 6.0
E. globulus 8.0 8.0 8.0 1.3
O. asteriscoides 8.0 8.0 8.0 0.6
Controls ciprofloxacin/amphotericin B 6.3 E-03 2.3 E-04 6.3 E-04 3.1 E-03
658 S. Suliman et al. / South African Journal of Botany 76 (2010) 655–661The antimicrobial activity ofA. afra essential oils has previously
been reported (Graven et al., 1992; Gundidza, 1993; Mangena and
Muyima, 1999; Huffman et al., 2002; Scott et al., 2004; Van
Vuuren and Viljoen, 2006; Viljoen et al., 2006a; Van Vuuren,
2007; Liu et al., 2009). Many of these studies only reported results
obtained using the disc diffusion assay. This, together with
chemotypic variation previously noted for A. afra (Viljoen et al.,
2006a) makes it difficult to compare results. However, the resultsFig. 1. Isobologram representation of the combinations of A. afra with A. betulina, Aare mostly congruent with our previous studies in which we used
the same chemotype (VanVuuren andViljoen, 2006;Viljoen et al.,
2006a; Van Vuuren, 2007). The antimicrobial activity of
A. betulina essential oil has been reported by Lis-Balchin et al.
(2001), Viljoen et al. (2006b) and Moolla and Viljoen (2008).
Where comparable, the results confer favourably with previous
studies.E. globulus essential oil has beenwidely studied and said to
have a broad spectrum of antibacterial and antifungal activity. afra with E. globulus, and A. afra with O. asteriscoides against four pathogens.
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Ghalem and Mohamed, 2008a,b). A recent study indicated potent
antimicrobial activity (51.4–85.6 μg/ml) against five pathogens
including methicillin-resistant Staphylococcus aureus (Tohidpour
et al., 2010). The MIC values for E. globulus reported here were
modest in comparison. The antimicrobial activity of O. aster-
iscoides is well known, even though different methodologies were
used to determine antimicrobial activity (Huffman et al., 2002;
Viljoen et al., 2003; Scott et al., 2004).
The essential oil compositions for these species have
previously been reported and are thus not elaborated on here
(Viljoen et al., 2003, 2006a,b; Maciel et al., 2010).
3.2. Fractional inhibitory concentration (FIC) and
isobologram construction
The MIC results for all combinations of A. afra with
E. globulus, A. afra with O. asteriscoides as well the
combination of A. afra with A. betulina, against the four
pathogens are shown as isobolograms (Fig. 1). The calculated
FIC data used to plot the ratios are presented in Table 3. All
positive and negative controls were within acceptable ranges
and responded in accordance with the test procedures. With the
combination of A. afra and A. betulina (Fig. 1), predominantly
additive interactions were noted for all pathogens studied. No
antagonism was observed and only three combinations (8:2 and
7:3 ratios with M. catarrhalis and 9:1 with E. faecalis where
A. afra was dominant) displayed non-interactive antimicrobial
interactions. The A. afra:A. betulina interaction displaying the
most prominent additive interaction was observed with the
pathogen M. catarrhalis where close to synergistic interactions
(0.6) were observed for two ratios (2:8 and 1:9, where
A. betulina essential oil was dominant).
For the combination of A. afra with E. globulus (Fig. 1;
Table 3), additive interactions at FIC value 1.0 were mostly
noted for all ratios against all the pathogens studied. It is only
with the pathogen M. catarrhalis that lower additive values
(0.7–0.9) were observed. As with the A. afra:A. betulina
combination, no antagonism was observed. Furthermore, non-
interactive combinations were not evident.
When A. afra was combined with O. asteriscoides, additive
interactions with FIC values of 1.0 were evident in all ratios for
M. catarrhalis, K. pneumoniae and E. faecalis. Two exceptions
were noted for the pathogen K. pneumoniae where ratios 3:7 and
2:8 (O. asteriscoides is dominant) showedminor variations (0.8) of
additivity. The most pronounced synergistic combination of all
A. afra combinations tested in this study was the 8:2 ratio (8 parts
A. afra with 2 parts O. asteriscoides) against C. neoformans
displaying an FIC value of 0.5.
It is well known that medicinal plants have been used since
antiquity to treat common infectious diseases and it has long
been acknowledged that essential oils exhibit antimicrobial
properties. Moreover, the use in combination to potentiate
antimicrobial activity has been addressed in a number of studies.
A disc diffusion study carried out by Geda (1995) on various
essential oil combinations commonly used in India revealed
synergistic interactions for selected combinations. Other studies
660 S. Suliman et al. / South African Journal of Botany 76 (2010) 655–661include the combination of Syzygium aromaticum L. (clove) and
Rosmarinus officinalis L. (rosemary) essential oils, where time-
kill methodology was used to demonstrate additive, synergistic
and antagonistic effects depending on the micro-organism tested
(Fu et al., 2007). A combination of Thymus vulgaris L. (thyme)
and Pimpinella anisum L. (anise) essential oil using broth micro-
dilution methods reported varying efficacies depending on
pathogen tested (Al-Bayati, 2008).
Even though a number of interactive studies have been
undertaken, few have incorporated isobolograms, which have
been used to describe synergy since 1978 (Berenbaum, 1978).
Only recently, have studies incorporated isobologram representa-
tion for plant-based interactions (Kamatou et al., 2006; Iten et al.,
2009; Van Vuuren and Viljoen 2009; Van Vuuren et al., 2009).
Other than Kamatou et al. (2006) wherein Salvia chamelaeagnea
and Leonotis leonurus was combined and tested for interactive
antimicrobial principles, and the combination of A. afra with
Lippia javanica essential oils by Van Vuuren (2007), no other
studies have been undertaken on combinations of aromatic South
African medicinal plants.
Although the mechanism of action of plant combinations
have not been adequately explored, there is the thought that
when used in combination, plants may provide many more
compounds that act at multiple target sites and therefore act
synergistically to increase effectiveness (Al-Bayati, 2008;
Biavatti, 2009). One must also take cognisance of the traditional
method of administration for many indigenous aromatic
medicinal plants, which is the burning of plant material
whereby the volatile components are released and inhaled.
The mode of administration allows biologically active com-
pounds to diffuse through the alveoli of the lungs and into the
bloodstream (Mohagheghzadeh et al., 2006; Braithwaite and
Viljoen, 2008). Furthermore, the lungs (which are predomi-
nantly affected in respiratory infections) are then the first target
for therapy. The predominant additive interactions noted in
the combination of A. afra with A. betulina, E. globulus or
O. asteriscoides (Table 3; Fig. 1) lend credibility to their
traditional use as a combined treatment against respiratory
infections. Although only one synergistic interaction was
observed, it was interesting to note that no antagonism and
very little non-interaction was evident, making these combina-
tions a viable option to explore further. Whether the aromatic
plant combinations studied here provide an additive effect when
administered clinically, should be investigated further.
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